Tool is freely available for researchers and conforms to evolving research guidelines

CHOP announced it has entered into a Memorandum of Understanding (MOU) with Sidra Medicine, a specialty healthcare organization for women, children and young people in Qatar.

In a landmark study, an international consortium led by researchers at CHOP published the final results of a key clinical trial of the gene therapy CASGEVY for the treatment of sickle cell disease.

Dr. Yael Mossé receives recognition for project dedicated to researching and potentially developing new therapies for undruggable solid tumors.

Showcasing its longstanding partnership with the United Arab Emirates Health Services, CHOP will exhibit thought-leading clinical research in the EHS booth at the Arab Health 2024 Exhibition and Congress in Dubai.

Distinguished pediatric oncologist John M. Maris, MD, has been named a member of the 2024 class of fellows of the American Association for Cancer Research (AACR) Academy. Each year, the AACR Academy recognizes and honors esteemed scientists whose major contributions have propelled significant innovation and progress against cancer.

The Food and Drug Administration (FDA) has approved CASGEVY™ (exagamglogene autotemcel) and LYFGENIA™ (lovotibeglogene autotemcel), the first two gene therapies for the treatment of sickle cell disease  in patients 12 years and older with recurrent vaso-occlusive crises (VOCs). 

Children’s Hospital of Philadelphia (CHOP) has received a $6.4 million gift from the family of Connor Boyle, a Central Bucks East High School graduate who died at age 18 from osteosarcoma. This three-year gift, named The Connor Initiative: Precision Therapeutics for Osteosarcoma & Rare Cancers, will support cutting-edge research in osteosarcoma and other rare cancers.

Dr. Mossé and her team, named KOODAC, will now compete for a chance to receive up to $25 million to tackle some of cancer's toughest challenges.

Children’s Hospital of Philadelphia (CHOP) has announced the establishment of the Punchard Family Endowed Chair in Translational Sarcoma Research. Patrick J. Grohar, MD, PhD, an attending physician with the Cancer Center and the Director of Translational Research with the Center for Childhood Cancer Research at CHOP, has been named the inaugural chair holder.